Thread: New Therapies Targeting Alpha-synuclein may Cause Harm
View Single Post
Old 03-24-2013, 05:12 PM
Debi Brooks Debi Brooks is offline
Member
  
Join Date: Feb 2009
Posts: 312
15 yr Member
Debi Brooks Debi Brooks is offline
Member
 
Join Date: Feb 2009
Posts: 312
15 yr Member
Default more info
Alpha Syneclein is a high priority target for PD drug development. More info on this finding in context can be found at our blog.

https://www.michaeljfox.org/foundati...e-in-parkinson

Debi
Debi Brooks is offline   Reply With QuoteReply With Quote
"Thanks for this!" says:
olsen (03-24-2013), Thelma (03-24-2013)